Search research articles
Contact Us
Filters
Showing results (191-200 of 477) with videos related to
Page
of 48
Sort By:
Journal of Scleroderma and Related Disorders
|
May 19, 2022
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II Cohort
Sangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, et al.
RMD Open
|
January 31, 2024
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis
Philip J Mease, Soumya Reddy, Sarah Ross, et al.
Journal of Clinical Epidemiology
|
November 13, 2015
Modified intention-to-treat analysis did not bias trial results
Anna Dossing, Simon Tarp, Daniel E Furst, et al.
Rheumatology International
|
February 6, 2019
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
Vivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Rheumatology (Oxford, England)
|
February 11, 2015
Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis
Beth Wallace, Suzanne Kafaja, Daniel E Furst, et al.
The Journal of Rheumatology
|
June 3, 2015
Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study
Sarah D Mills, Rina S Fox, Erin L Merz, et al.
The Journal of Rheumatology
|
January 14, 2004
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)
Daniel E Furst, Michael H Schiff, Roy M Fleischmann, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
August 18, 2015
Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis
Sarah S Thomas, Nabeel Borazan, Nashla Barroso, et al.
Blood
|
September 28, 2002
Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer
Nathalie C Lambert, Y M Dennis Lo, Timothy D Erickson, et al.
Arthritis Research & Therapy
|
February 4, 2014
Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year
Jonathan Kay, Olga Morgacheva, Susan P Messing, et al.
Page
of 48
Search research articles
Search
Showing results (191-200 of 477) with videos related to
Sort By:
Page
of 48
Journal of Scleroderma and Related Disorders
|
May 19, 2022
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II Cohort
Sangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, et al.
RMD Open
|
January 31, 2024
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis
Philip J Mease, Soumya Reddy, Sarah Ross, et al.
Journal of Clinical Epidemiology
|
November 13, 2015
Modified intention-to-treat analysis did not bias trial results
Anna Dossing, Simon Tarp, Daniel E Furst, et al.
Rheumatology International
|
February 6, 2019
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
Vivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Rheumatology (Oxford, England)
|
February 11, 2015
Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis
Beth Wallace, Suzanne Kafaja, Daniel E Furst, et al.
The Journal of Rheumatology
|
June 3, 2015
Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study
Sarah D Mills, Rina S Fox, Erin L Merz, et al.
The Journal of Rheumatology
|
January 14, 2004
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)
Daniel E Furst, Michael H Schiff, Roy M Fleischmann, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
August 18, 2015
Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis
Sarah S Thomas, Nabeel Borazan, Nashla Barroso, et al.
Blood
|
September 28, 2002
Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer
Nathalie C Lambert, Y M Dennis Lo, Timothy D Erickson, et al.
Arthritis Research & Therapy
|
February 4, 2014
Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year
Jonathan Kay, Olga Morgacheva, Susan P Messing, et al.
Page
of 48